Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Metabolic dysfunction–associated steatohepatitis (MASH) is a form of liver disease that can progress ... to evaluate the GLP-1 receptor agonist semaglutide in patients with MASH and stage ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Due to its role in managing diabetes, Ozempic, the brand name for the medication semaglutide, is gaining a lot of attention.

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.